SEC Filings

PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 05/07/2019
Entire Document

Exhibit 99.1




In re: Pernix Sleep, Inc. et al. Case No. 19-10323 (CSS)
Debtors Reporting Period: February 18, 2019 - March 31, 2019


File with Court and submit copy to United States Trustee within 20 days after end of month.


Submit copy of report to any official committee appointed in the case.


REQUIRED DOCUMENTS Form No. Document Attached



Affidavit/Supplement Attached
Schedule of Cash Receipts and Disbursements MOR-1 X    
Schedule of Disbursements by Debtor Entity MOR-1a X    
Schedule of Debtor Bank Account Balances MOR-1b X    
Schedule of Professional Fees and Expenses Paid MOR-1c X    
Copies of bank statements       Certification Attached
Cash disbursements journals       Certification Attached
Bank reconciliation       Certification Attached
Statement of Operations MOR-2 X    
Balance Sheet MOR-3 X    
Status of Postpetition Taxes       Certification Attached
Copies of IRS Form 6123 or payment receipt       Certification Attached
Copies of tax returns filed during reporting period       Certification Attached
Summary of Unpaid Postpetition Debts        
Summary of Unpaid Post Petition Accounts Payables MOR-4 X    
Accounts Receivable Aging MOR-5 X    
Debtor Questionnaire MOR-5 X    


I declare under penalty of perjury (28 U.S.C. Section 1746) that this report and the attached documents are true and correct to the best of my knowledge and belief.


/s/ Glenn Whaley   April 30, 2019
Signature of Authorized Individual*   Date


Glenn Whaley   VP Finance, Principal Financial and Accounting Officer
Printed Name of Authorized Individual   Title of Authorized Individual


*Authorized individual must be an officer, director or shareholder if debtor is a corporation; a partner if debtor
is a partnership; a manager or member if debtor is a limited liability company.



The Debtors in these chapter 11 cases, along with the last four digits of each Debtor’s federal tax identification number, as applicable, are: Pernix Sleep, Inc. (1599), Cypress Pharmaceuticals, Inc. (1860), Gaine, Inc. (3864), Hawthorn Pharmaceuticals, Inc. (2769), Macoven Pharmaceuticals, L.L.C. (4549), Pernix Holdco 1, LLC, Pernix Holdco 2, LLC, Pernix Holdco 3, LLC, Pernix Ireland Limited, Pernix Ireland Pain Designated Activity Company, Pernix Manufacturing, LLC (1236), Pernix Therapeutics Holdings, Inc. (4736), Pernix Therapeutics, LLC (1128) and Respicopea, Inc. (1303). The Debtor’s mailing address for purposes of this chapter 11 case is 10 North Park Place Suite 201, Morristown, NJ 07960.